Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.

Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, Janetzko A, Wiederholt T, Berg T, Müller T, Trautwein C, Gressner AM, Weiskirchen R.

J Viral Hepat. 2009 Sep;16(9):612-20. doi: 10.1111/j.1365-2893.2009.01110.x. Epub 2009 Feb 20.

PMID:
19243500
2.

Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis.

Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM.

Clin Chim Acta. 2002 Feb;316(1-2):83-94.

PMID:
11750277
3.

Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.

Gressner OA, Fang M, Li H, Lu LG, Gressner AM, Gao CF.

Clin Chim Acta. 2013 Jun 5;421:126-31. doi: 10.1016/j.cca.2013.02.029. Epub 2013 Mar 15.

PMID:
23501329
4.

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.

Gressner OA, Gressner AM.

Liver Int. 2008 Sep;28(8):1065-79. doi: 10.1111/j.1478-3231.2008.01826.x. Review.

PMID:
18783549
5.

Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis.

Gressner AM, Yagmur E, Lahme B, Gressner O, Stanzel S.

Clin Chem. 2006 Sep;52(9):1815-7. Epub 2006 Jul 20.

6.

Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis.

Piao RL, Brigstock DR, Zhu J, Zhang ML, Gao RP.

World J Gastroenterol. 2012 May 14;18(18):2280-6. doi: 10.3748/wjg.v18.i18.2280.

7.

The level of connective tissue growth factor in sera of patients with hepatitis B virus strongly correlates with stage of hepatic fibrosis.

Guo-Qiu W, Nai-Feng L, Xiao-Bo V, Linxian L, Chen Z, Lixia G, Zhao L.

Viral Immunol. 2010 Feb;23(1):71-8. doi: 10.1089/vim.2009.0067.

PMID:
20121404
8.

Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C.

Hora C, Negro F, Leandro G, Oneta CM, Rubbia-Brandt L, Muellhaupt B, Helbling B, Malinverni R, Gonvers JJ, Dufour JF; Swiss Hepatitis C Cohort Study Group.

Liver Int. 2008 Mar;28(3):370-6. Epub 2007 Nov 1.

PMID:
17976159
9.

Connective tissue growth factor expression is increased in biliary epithelial cells in biliary atresia.

Narkewicz MR, Kasaragod A, Lucia MS, Pflummer S, Sokol RJ, Stenmark KR.

J Pediatr Surg. 2005 Nov;40(11):1721-5.

PMID:
16291159
10.

Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia.

Tamatani T, Kobayashi H, Tezuka K, Sakamoto S, Suzuki K, Nakanishi T, Takigawa M, Miyano T.

Biochem Biophys Res Commun. 1998 Oct 29;251(3):748-52.

PMID:
9790981
11.

Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K.

J Rheumatol. 2000 Jan;27(1):149-54.

PMID:
10648031
12.

Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis.

Dendooven A, Gerritsen KG, Nguyen TQ, Kok RJ, Goldschmeding R.

Biomarkers. 2011 Jun;16(4):289-301. doi: 10.3109/1354750X.2011.561366. Review.

PMID:
21595567
13.
14.

Transforming growth factor-beta 1 in chronic hepatitis C.

Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, Davis GL, Lau JY.

J Viral Hepat. 1997 Jan;4(1):29-35.

PMID:
9031062
15.

Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF).

Kono M, Nakamura Y, Suda T, Kato M, Kaida Y, Hashimoto D, Inui N, Hamada E, Miyazaki O, Kurashita S, Fukamachi I, Endo K, Ng PS, Takehara K, Nakamura H, Maekawa M, Chida K.

Clin Chim Acta. 2011 Nov 20;412(23-24):2211-5. doi: 10.1016/j.cca.2011.08.008. Epub 2011 Aug 12.

PMID:
21864521
16.

Correlation of Connective Tissue Growth Factor (CTGF/CCN2) with Hepatic Fibrosis in Chronic Hepatitis B.

Ferdoushi S, Paul D, Ghosh CK, Sultana T, Joarder AI, Islam MS, Islam MS, Mahmuduzzaman M, Rahman Q, Ahmed AN.

Mymensingh Med J. 2015 Jul;24(3):558-63.

PMID:
26329955
17.

Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis C.

Miyoshi K, Ikebuchi Y, Ishida C, Okamoto K, Murawaki Y.

Intern Med. 2014;53(14):1461-8. Epub 2014 Jul 15.

18.

Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population.

Kawaguchi Y, Ota Y, Kawamoto M, Ito I, Tsuchiya N, Sugiura T, Katsumata Y, Soejima M, Sato S, Hasegawa M, Fujimoto M, Takehara K, Kuwana M, Yamanaka H, Hara M.

Ann Rheum Dis. 2009 Dec;68(12):1921-4. doi: 10.1136/ard.2008.100586. Epub 2008 Dec 3.

PMID:
19054818
19.

Evidence for the involvement of TGF-β1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection.

Tache D, Bogdan F, Pisoschi C, Baniţă M, Stănciulescu C, Fusaru AM, Comănescu V.

Rom J Morphol Embryol. 2011;52(1 Suppl):409-12.

20.

Supplemental Content

Support Center